Catalogo dei prodotti della ricerca

VIZZA, Carmine Dario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.003
EU - Europa 3.356
AS - Asia 1.500
SA - Sud America 73
AF - Africa 56
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.001
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.912
IT - Italia 1.713
SG - Singapore 692
SE - Svezia 427
IN - India 385
UA - Ucraina 341
CN - Cina 251
FI - Finlandia 216
DE - Germania 152
GB - Regno Unito 130
FR - Francia 73
CA - Canada 66
BG - Bulgaria 60
ID - Indonesia 56
NL - Olanda 53
TG - Togo 49
AR - Argentina 48
IE - Irlanda 41
RO - Romania 32
IR - Iran 22
MX - Messico 22
CH - Svizzera 20
HK - Hong Kong 19
BE - Belgio 18
LT - Lituania 16
TR - Turchia 11
GR - Grecia 10
PH - Filippine 10
RU - Federazione Russa 10
BR - Brasile 9
TW - Taiwan 9
ES - Italia 8
PL - Polonia 8
MY - Malesia 7
CL - Cile 6
CO - Colombia 6
JP - Giappone 6
AT - Austria 5
AU - Australia 5
PT - Portogallo 5
TH - Thailandia 5
VN - Vietnam 5
EU - Europa 4
KR - Corea 4
HR - Croazia 3
LB - Libano 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
AZ - Azerbaigian 2
BD - Bangladesh 2
EG - Egitto 2
IL - Israele 2
LU - Lussemburgo 2
MA - Marocco 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
ZA - Sudafrica 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
IQ - Iraq 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SC - Seychelles 1
SI - Slovenia 1
Totale 12.001
Salva come PNG Salva come JPEG
Città #
Fairfield 931
Chandler 541
Singapore 493
Woodbridge 476
Rome 470
Ashburn 439
Seattle 351
Cambridge 331
Houston 296
Wilmington 296
Ann Arbor 291
Princeton 259
Dearborn 252
Santa Clara 167
Plano 164
Beijing 145
Milan 125
Jacksonville 119
San Diego 116
San Paolo di Civitate 115
Boston 107
Lawrence 101
Millbury 89
Andover 60
Sofia 59
Des Moines 57
Jakarta 56
Boardman 52
Lomé 49
New York 48
Federal 45
Toronto 45
Helsinki 41
Dublin 40
Fremont 38
Bremen 37
Norwalk 27
Southend 24
Groningen 22
Lappeenranta 21
Naples 20
Mannheim 19
San Mateo 19
Brussels 18
Bühl 18
London 18
Falls Church 16
Bergamo 15
Hefei 15
Leawood 15
Turin 14
Bari 13
Klaipėda 13
Kunming 13
Florence 12
Nanjing 11
Paris 10
Bologna 9
Falkenstein 9
Grafing 9
Rende 9
Verona 9
Zanjan 9
Beauharnois 8
Catania 8
Dallas 8
Padova 8
Puebla City 8
Stockholm 8
Amsterdam 7
Lowestoft 7
Ottawa 7
Torino 7
Cardito 6
Central 6
Jinan 6
Marino 6
Mexico City 6
Phoenix 6
Pune 6
Temuco 6
Treviso 6
Trieste 6
Atlanta 5
Bogotá 5
Chengdu 5
Coyoacán 5
Custonaci 5
Genoa 5
Kuala Lumpur 5
Monza 5
Nanchang 5
Nocera Superiore 5
Palermo 5
Riva del Garda 5
Taranto 5
Adelfia 4
Amandola 4
Athens 4
Balzola 4
Totale 7.925
Salva come PNG Salva come JPEG
Nome #
Significato del sottoslivellamento del tratto ST nelle derivazioni precordiali in corso di infarto miocardico acuto della parete inferiore 722
Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension 121
Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients. a clinical trial 115
Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension 109
Echocardiography combined with cardiopulmonary exercise testing for the prediction of outcome in idiopathic pulmonary arterial hypertension 105
Right heart and pulmonary vessels structure and function 100
Letter to the editor about the paper “right ventricular dyssynchrony predicts clinical outcomes in patients with pulmonary hypertension” by murata et al 100
Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging 98
Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension 96
Ruolo prognostico a lungo termine dell'ipertensione polmonare nei pazienti con acuta decompensated heart failure : valutazione all'ingresso in ospedale e in pre-dimissione. Roberto Badagliacca, Stefano Ghio, Michele Correale, Pasquale Petrone, Giordana Ferraioli, Beatrice Pezzuto, Roberto Poscia, Laura Scelsi, Giovanna Manzi, Silvia Papa, Daniele Berardi, Ferraretti Armando, Francesco Fedele, Carmine Dario Vizza 95
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension. 95
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension 93
Transesophageal dipyridamole echocardiography for diagnosis of coronary artery disease. 93
The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension 91
Human Herpesvirus 8 and Pulmonary Hypertension. 90
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 89
Right ventricular remodeling in idiopathic pulmonary arterial hypertension. adaptive versus maladaptive morphology 88
Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension. 84
Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: Results of the COMPASS-1 study 83
Cardiovascular effects of chronic sildenafil in men with type 2 diabetes 82
Ambrisentan for the treatment of adults with pulmonary arterial hypertension. a review 82
Circulating biomarkers in pulmonary arterial hypertension. update and future direction 82
Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study. 80
Pulmonary hemodynamics contribute to indicate priority for lung transplantation in patients with cystic fibrosis 80
Mortality in pulmonary arterial hypertension. prediction by the 2015 european pulmonary hypertension guidelines risk stratification model 80
Right intraventricular dyssynchrony in idiopathic, heritable, and anorexigen-induced pulmonary arterial hypertension. Cllinical impact and reversibility 80
Tissue-type plasminogen activator therapy versus primary coronary angioplasty: Impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction 79
Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease 78
Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial 78
Abnormal behavior of the forearm vasculature during ergometric test in hypertrophic cardiomyopathy 77
Right ventricular dyssynchrony in idiopathic pulmonary arterial hypertension: determinants and impact on pump function 76
Right ventricular strain curve morphology and outcome in idiopathic pulmonary arterial hypertension 76
Response to letters regarding article, "anticoagulation and survival in pulmonary arterial hypertension: Results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)" 75
Usefulness of adding echocardiography of the right heart to risk-assessment scores in prostanoid-treated pulmonary arterial hypertension 74
Pulmonary Arterial Dilatation in Pulmonary Hypertension: Prevalence and Prognostic Relevance 73
Changes in Right Ventricular Function Measured by Cardiac Magnetic Resonance Imaging in Patients Receiving Pulmonary Arterial Hypertension-Targeted Therapy The EURO-MR Study 72
Locoregional versus general anesthesia in carotid surgery: Is there an impact on peri-operative myocardial ischemia? Results of a prospective monocentric randomized trial. 72
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension 72
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease. a randomized controlled multicenter clinical trial 72
An official european respiratory society statement. pulmonary haemodynamics during exercise 72
Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study 71
Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: Retrospective results from six European countries 71
Identification of coronary artery by-pass grafts: reliability of MRI in clinical practice. 70
Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension 70
Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics 70
Improved results with lung transplantation for cystic fibrosis 69
Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy. the impact of late referral. 69
Clinical impact of echocardiography in prognostic stratification after acute myocardial infarction 69
Relationship between baseline ET-1 plasma levels and outcome in patients with idiopathic pulmonary hypertension treated with bosentan 69
Heart failure pharmacological management. gaps and current perspectives 68
Tissue viability by contrast echocardiography 68
Usefulness of 2D echo Doppler in the preoperative assessment of cystic fibrosis patients who are candidates for lung transplantation 68
Timing and priorities for cystic fibrosis patients candidates to lung transplantation 67
Comparative Effects of Irbesartan Versus Amlodipine on Left Ventricular Mass Index in Hypertensive Patients with Left Ventricular Hypertrophy 67
Efficacy of 1, 5, and 20mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension. a randomized, double-blind study with open-label extension 67
Prognostic significance of the echocardiographic estimate of pulmonary hypertension and of right ventricular dysfunction in acute decompensated heart failure. a pilot study in HFrEF patients 67
Echo stress in functional evaluation of dilated cardiomyopathy. 66
'Real-life' information on pulmonary arterial hypertension: The iPHnet Project 66
Myocardial and microvascular inflammation/infection in patients with HIV-associated pulmonary artery hypertension 66
Usefulness of the dipyridamole-Doppler test for diagnosis of coronary artery disease 65
Myocardial and micro-vascular inflammation/infection in HIV/HCV associated pulmonary artery hypertension 65
Cardiovascular effects of chronic sildenafil treatment in men with type 2 diabetes 65
Cardiac and vascular remodeling after 6 months of therapy with sacubitril/valsartan. mechanistic insights from advanced echocardiographic analysis 65
Occult lung cancer in patients with bullous emphysema 64
Effetti Cardiovascolari della Somministrazione in Cronico di Sildenafil in Soggetti con ?Diabete Mellito di tipo 2 63
Supravalvular aortic stenosis and pulmonary artery stenosis: echocardiographic and clinical aspects. 63
Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): Safety, tolerability, clinical, and haemodynamic effect 63
Unusual presentation for a patent ductus arteriosus 63
Preoperative evaluation of patients undergoing lung resection surgery. defining the role of the anesthesiologist on a multidisciplinary team 63
Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial 63
Assessment of right ventricular inotropic reserve during dobutamine infusion in patients with secondary pulmonary hypertension. 61
Pulmonary arterial hypertension: current therapies. 61
Safety and efficacy evaluation of ambrisentan in pulmonary hypertension 61
Validità dell'ecocardiografia nella valutazione della terapia cardiovascolare 60
Outcome of Patients with Cystic Fibrosis Awaiting Lung Transplantation 60
Endogenous opioid system modulation in anginal pain: demonstration of its central activity. 60
2019 ESC guidelines for the dignosis and management of acute pulmonary embolism developed in collaboration with the european respiratory society (ERS) 60
Endocrine and metabolic alterations in patients with pulmonary arterial hypertension 59
Hemodynamics during inhaled nitric oxide in lung transplant candidates 59
Dal Tromboembolismo Venoso all’Ipertensione Polmonare cronica tromboembolica 58
La terapia di combinazione orale nel trattamento dei pazienti con ipertensione arteriosa polmonare. quali evidenze dagli studi a lungo termine [Oral combination therapy for the treatment of patients with pulmonary arterial hypertension. what evidence from long-term studies] 58
Badagliacca R, Papa S, Valli G, Pezzuto B, Poscia R, Murace AC, Marinelli L, Manzi G, Berardi D, Sciomer S, Palange P, Fedele F, Vizza CD. “Incremental benefit of cardiopulmonary exercise testing for the prediction of outcome in stable prevalent idiopathic pulmonary arterial Hypertension patients”. Comunicazione Abstract del 77° Congresso Nazionale della Società Italiana di Cardiologia (2016) 58
PROSTANOID THERAPY FOR PULMONARY ARTERIAL HYPERTENSION. 57
Pulmonary hypertension in patients with chronic fibrosing idiopathic interstitial pneumonias 57
The growing role of echocardiography in pulmonary arterial hypertension risk stratification. the missing piece 57
Complex connections, a young man presenting with shortness of breath, hypoxemia, right lumbar pain and left limb swelling 57
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. 56
Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction. 56
Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension 56
RESPITE. switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors 56
Right ventricular assessment matters for precision medicine.. reply to "Identifying parameters associated with response to switching from a PDE5i to riociguat in RESPITE" 56
Acute pulmonary vascular response to inhaled nitric oxide,dobutamine and their association in patients with secondary pulmonary hypertension. 55
Inhaled areosolized prostacyclin and pulmonary hypertension during anesthesia for lung transplantation 55
Peripheral arterial stiffness in acute pulmonary embolism and pulmonary hypertension at short-term follow-up 55
Reconstruction of the pulmonary artery by a conduit of autologous pericardium. 55
Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. 55
Medical management of right ventricular dysfunction in pulmonary arterial hypertension 54
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. 54
Isolated lung transplantation for end-stage lung disease 54
[Role of the endogenous opioid system in the modulation of anginal pain]. 53
Totale 7.792
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.118
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.583 0 0 0 0 178 373 287 238 197 150 108 52
2020/20211.195 90 101 43 93 54 94 29 95 203 272 93 28
2021/20222.332 49 130 159 82 245 50 54 186 223 285 411 458
2022/20232.480 461 408 144 261 259 273 25 146 260 45 140 58
2023/20241.573 79 199 90 105 152 160 93 127 27 193 149 199
2024/20251.162 135 214 338 195 280 0 0 0 0 0 0 0
Totale 12.602